Katja Thomas

13PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyMicrobial geneticsMajor global burdens of diseaseNeurology and neuromuscular diseasesPsychiatry (incl. psychotherapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 26, 2025
Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.

Hannah Solchenberger, Marcus Odendahl, Dirk Schriefer

|Sep 14, 2024
Raman Spectroscopy of Optically Trapped Living Human T Cell Subsets and Monocytes.

Martin Nötzel, Maria Mahamid, Romy Kronstein-Wiedemann

|Jun 27, 2024
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma.

Georges Katoul Al Rahbani, Christina Woopen, Marie Dunsche

|Mar 28, 2024
Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort.

Hernan Inojosa, Dirk Schriefer, Yassin Atta

|Feb 14, 2024
Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance.

Tony Sehr, Katja Akgün, Pascal Benkert

|Oct 10, 2023
Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis.

Elias S Sotirchos, Chen Hu, Matthew D Smith

Pageof 3

Frequent Collaborators

13 joint publications

Tjalf Ziemssen

5 joint publications

Rocco Haase

4 joint publications

Dirk Schriefer

3 joint publications

Raimar Kern